Itโ€™s a wrap San Diego! #BIO2024

Itโ€™s a wrap San Diego! ๐Ÿ‡บ๐Ÿ‡ธ We are leaving #BIO2024 after a lot of exciting encounters, discussions and conferences. The ecosystem is thriving with opportunities and BIO is for sure an inspiring moment to share among peers. Our very special thanks goes to Business France Healthcare – North America and Lyonbiopรดle Auvergne-Rhรดne-Alpes for such a warm welcome, we always feel at home at the French Pavilion. See u soon

Onco Startup Summit โ†’ Financements Non-dilutifs : “Comment naviguer ร  travers les possibilitรฉs et faire les bons choix”

๐Ÿ“ข ๐—ข๐—ป๐—ฐ๐—ผ๐—ฆ๐˜๐—ฎ๐—ฟ๐˜๐˜‚๐—ฝ ๐—ฆ๐˜‚๐—บ๐—บ๐—ถ๐˜ ! Tout juste rentrรฉ du BIO, Paul Bravetti sera ร  Paris demain (13/06) pour parler de #Financements non-dilutifs. Depuis le dรฉbut, Brenus Pharma construit une solide stratรฉgie non-dilutive pour supporter ses dรฉveloppements dรฉdiรฉs ร  lโ€™innovation en oncologie. โžก๏ธRรฉcemment laurรฉate de l’AaP #Biothรฉrapies dans le cadre du plan de financement France 2030, Brenus Pharma reรงoit un soutien de lโ€™Etat et la BPI dans le dรฉveloppement clinique du premier candidat issu de la plateforme #STC. ๐ŸคฉNous sommes heureux de retrouver nos partenaires et accรฉlรฉrateurs Paris Saclay Cancer Cluster (PSCC), MATWIN qui coorganisent cette journรฉe avec Angels Santรฉ, Gustave Roussy Transfert et OncoSTART โ€“ avec le soutien institutionnel de Medicen Paris Region, France Biotech, le SNITEM et la Filiรจre Intelligence Artificielle & Cancers. [Table Ronde 1 : 9h45 โ€“ 10h25] La discussion sโ€™annonce captivante avec Armelle Graciet – SNITEM Etienne Lonchamp – Medicen Paris Region Paul Bravetti – Brenus Pharma Aline Cerf – SmartCatch Nikos Paragios – TheraPanacea Jean-Christophe Braun – In Extenso Innovation Croissance Programme complet : https://lnkd.in/ejCTV7pD #Biotech #Innovation #Startup #Cancer

Creative Destruction Lab – Graduates of 2023/2024

We are excited to highlight the graduates of the CDL-Global #AdvancedTherapies and #Cancer streams this year. A big round of applause to the dedication of the ventures throughout the program. These companies are at the forefront of innovation in #healthtech and are set to make a significant impact in the industry. CDL-Global Streams are supported by multiple sites, attracting top ventures and mentors from around the world. In the 2023/24 program cycle, CDL-Vancouver supported the Advanced Therapies Stream, in conjunction with CDL-Oxford, CDL-Toronto, and CDL-Wisconsin with founding partner CCRM as well as the Cancer Stream, in partnership with CDL-Toronto with founding partner Sociรฉtรฉ canadienne du cancer. Advanced Therapies Stream Graduates CereCura Nanotherapeutics, ForCell, Full Circles Therapeutics Inc., HDAX Therapeutics, HHC medical, Lilium Therapeutics, Mechano-Therapeutics LLC, MetaStem Therapeutics, Modulari-T Bio, MyoGene Bio, Noa Therapeutics, Pando Bioscience (YC W23) Cancer Stream Graduates Aperture Bio, Brenus Pharma, Case45, Concarlo Therapeutics, Encapsulate, NuvoBio, Oncoelectronics, OrisDX, Oxford Cancer Analytics, Realyze Intelligence

Join us at BIO International Convention #BIO2024

โŒ›Time is running out for the #BIO2024 International Convention, next week. Only a few slots are left to meet Paul Bravetti (CEO) and Lรฉa Perles (Strategic Operations Lead) โžก๏ธ๐—Ÿ๐—ผ๐—ด ๐—ถ๐—ป๐˜๐—ผ ๐—•๐Ÿฎ๐—• ๐—ฝ๐—ฎ๐—ฟ๐˜๐—ป๐—ฒ๐—ฟ๐—ถ๐—ป๐—ด ๐˜€๐˜†๐˜€๐˜๐—ฒ๐—บ for a 30′ meeting : https://lnkd.in/dBejSc4j A unique opportunity to discuss our latest advancements and explore new collaboration opportunities. ๐Ÿ“…Dates: [June 3-6] ๐Ÿ“Location: [San Diego, CA] Brenus Pharma is proud to be part of the esteemed delegations from Business France Healthcare – North America, ๐Ÿ‡ซ๐Ÿ‡ท French Healthcare Association, and Lyonbiopรดle Auvergne-Rhรดne-Alpes We’re excited to meet you there !๐Ÿคฉ #BIOInternationalConvention hashtag#Biotechnology hashtag#Innovation hashtag#Science hashtag#Networking hashtag#BIOUS2024

Join us at ASCO 2024

Next week at #ASCO24 ๐Ÿ’กโ€œ๐—•๐—ฟ๐—ฒ๐—”๐—ž ๐—–๐—ฅ๐—–, ๐—ฎ ๐—ณ๐—ถ๐—ฟ๐˜€๐˜-๐—ถ๐—ป-๐—ต๐˜‚๐—บ๐—ฎ๐—ป ๐—ฝ๐—ต๐—ฎ๐˜€๐—ฒ ๐—œ/๐—œ๐—œ ๐˜๐—ฟ๐—ถ๐—ฎ๐—น ๐—ผ๐—ณ ๐—ฆ๐—ง๐—–-๐Ÿญ๐Ÿฌ๐Ÿญ๐Ÿฌ, ๐—ฎ ๐—ป๐—ฒ๐˜„ ๐—ฎ๐—น๐—น๐—ผ๐—ด๐—ฒ๐—ป๐—ถ๐—ฐ ๐—ฐ๐—ฎ๐—ป๐—ฐ๐—ฒ๐—ฟ ๐˜ƒ๐—ฎ๐—ฐ๐—ฐ๐—ถ๐—ป๐—ฒ ๐—ณ๐—ผ๐—ฟ ๐—ฎ๐—ฑ๐˜ƒ๐—ฎ๐—ป๐—ฐ๐—ฒ๐—ฑ ๐—ผ๐—ฟ ๐—บ๐—ฒ๐˜๐—ฎ๐˜€๐˜๐—ฎ๐˜๐—ถ๐—ฐ ๐˜‚๐—ป๐—ฟ๐—ฒ๐˜€๐—ฒ๐—ฐ๐˜๐—ฎ๐—ฏ๐—น๐—ฒ ๐—ฐ๐—ผ๐—น๐—ผ๐—ฟ๐—ฒ๐—ฐ๐˜๐—ฎ๐—น ๐—ฐ๐—ฎ๐—ป๐—ฐ๐—ฒ๐—ฟ.โ€ Brenus Pharma is excited to present a new poster accepted at American Society of Clinical Oncology (ASCO) annual meeting in Chicago during the โ€œTrials in Progressโ€ session. โฌ‡๏ธ Contact & meet Corinne TORTORELLI, Poster hashtag#295b ๐Ÿ—“๏ธ 6/1/2024, 1:30 PM-4:30 PM CDT ๐Ÿ“ฃ”๐˜‰๐˜ณ๐˜ฆ๐˜ˆ๐˜’-๐˜Š๐˜™๐˜Š ๐˜ช๐˜ด ๐˜ฎ๐˜ฆ๐˜ข๐˜ฏ๐˜ต ๐˜ต๐˜ฐ ๐˜ค๐˜ญ๐˜ช๐˜ฏ๐˜ช๐˜ค๐˜ข๐˜ญ๐˜ญ๐˜บ ๐˜ค๐˜ฐ๐˜ฏ๐˜ง๐˜ช๐˜ณ๐˜ฎ ๐˜ต๐˜ฉ๐˜ฆ ๐˜ฑ๐˜ณ๐˜ฐ๐˜ฎ๐˜ช๐˜ด๐˜ช๐˜ฏ๐˜จ ๐˜ฑ๐˜ณ๐˜ฆ๐˜ค๐˜ญ๐˜ช๐˜ฏ๐˜ช๐˜ค๐˜ข๐˜ญ ๐˜ฐ๐˜ถ๐˜ต๐˜ค๐˜ฐ๐˜ฎ๐˜ฆ๐˜ด ๐˜ฐ๐˜ฃ๐˜ต๐˜ข๐˜ช๐˜ฏ๐˜ฆ๐˜ฅ ๐˜ฐ๐˜ฏ ๐˜ฅ๐˜ช๐˜ง๐˜ง๐˜ฆ๐˜ณ๐˜ฆ๐˜ฏ๐˜ต ๐˜ด๐˜บ๐˜ฏ๐˜จ๐˜ฆ๐˜ฏ๐˜ฆ๐˜ช๐˜ค ๐˜ฎ๐˜ฐ๐˜ถ๐˜ด๐˜ฆ ๐˜ฎ๐˜ฐ๐˜ฅ๐˜ฆ๐˜ญ๐˜ด ๐˜ข๐˜ฏ๐˜ฅ ๐˜ฆ๐˜น-๐˜ท๐˜ช๐˜ท๐˜ฐ ๐˜ข๐˜ด๐˜ด๐˜ข๐˜บ๐˜ด ๐˜ข๐˜ฃ๐˜ฐ๐˜ถ๐˜ต ๐˜ต๐˜ฉ๐˜ฆ ๐˜ฑ๐˜ฐ๐˜ต๐˜ฆ๐˜ฏ๐˜ต๐˜ช๐˜ข๐˜ญ ๐˜ฎ๐˜ข๐˜ซ๐˜ฐ๐˜ณ ๐˜ต๐˜ฉ๐˜ฆ๐˜ณ๐˜ข๐˜ฑ๐˜ฆ๐˜ถ๐˜ต๐˜ช๐˜ค ๐˜ช๐˜ฎ๐˜ฑ๐˜ข๐˜ค๐˜ต ๐˜ฐ๐˜ง ๐˜š๐˜›๐˜Š-1010 ๐˜ฐ๐˜ฏ ๐˜ฑ๐˜ข๐˜ต๐˜ช๐˜ฆ๐˜ฏ๐˜ต๐˜ด ๐˜ธ๐˜ช๐˜ต๐˜ฉ ๐˜ฑ๐˜”๐˜”๐˜™/๐˜”๐˜š๐˜š ๐˜ข๐˜ฏ๐˜ฅ ๐˜ฅ๐˜”๐˜”๐˜™/๐˜”๐˜š๐˜-๐˜ ๐˜๐˜Š๐˜-๐˜ณ๐˜ฆ๐˜ด๐˜ช๐˜ด๐˜ต๐˜ข๐˜ฏ๐˜ต ๐˜ข๐˜ฅ๐˜ท๐˜ข๐˜ฏ๐˜ค๐˜ฆ๐˜ฅ ๐˜ฐ๐˜ณ ๐˜ฎ๐˜ฆ๐˜ต๐˜ข๐˜ด๐˜ต๐˜ข๐˜ต๐˜ช๐˜ค ๐˜ถ๐˜ฏ๐˜ณ๐˜ฆ๐˜ด๐˜ฆ๐˜ค๐˜ต๐˜ข๐˜ฃ๐˜ญ๐˜ฆ ๐˜ค๐˜ฐ๐˜ญ๐˜ฐ๐˜ณ๐˜ฆ๐˜ค๐˜ต๐˜ข๐˜ญ ๐˜ค๐˜ข๐˜ฏ๐˜ค๐˜ฆ๐˜ณ๐˜ด” Stay tuned !! #Biotech hashtag#Immunotherapy hashtag#Cancervaccine hashtag#Colorectalcancer hashtag#Clinicalstudy hashtag#Oncology

Brenus Pharma, French ambassador #Boosters

Brenus Pharma, French ambassador #Boosters ! Last night we received the hashtag#Healthcare ๐Ÿ’™๐Ÿคโค๏ธ award from Business France, who are constantly and effectively committed to strengthening our international attractiveness and promoting our mission to meet the needs of patients, in France and beyond borders. We are honored to be recognized among a core group of innovative companies that share common values and goals in presence of the Minister Delegate in charge of Foreign Trade, Attractiveness, the Francophonie and the French Abroad Franck Riester and Business France CEO Laurent Saint-Martin.ย ๐Ÿ‘ Benjamin Hubert – Javelot | Adrien VIVES – Velou | Florence ROBIN – Limatech | Laure BOURDON – Haffner Energy Thank you to Business France Healthcare – North America teams who have been supporting us in the North American market for several years. Thank you to all jury members, partners (cc Sabrina Murphy, Mazars), and institutions behind this support. โฌ‡๏ธ #ChooseFrance hashtag#Osezlexport hashtag#TeamFranceExport

Join us at MEET2WIN 2024

Join us tomorrow at the #Meet2Win – European Oncology Partnering Convention in Bordeaux ๐Ÿ“ organized by MATWIN ! Thank you for bringing us the opportunity to present Brenus Pharma‘s latest developments and upcoming collaboartions during the “๐™ˆ๐™€๐™€๐™ ๐™ˆ๐™ฎ ๐˜ผ๐™ก๐™ข๐™ช๐™ฃ๐™ž ๐™‹๐™Š๐™Ž๐™๐™€๐™ ๐™Ž๐™€๐™Ž๐™Ž๐™„๐™Š๐™‰” [16th โฒ๏ธ 6 to 7 pm – HALL & 17th โฒ๏ธ10 to 11 am – Room Brasilia] Paul Bravetti and Lรฉa Perles are excited to attend this 9th edition, and connect with you. #Biotechnology hashtag#Innovation hashtag#Accelerator hashtag#European hashtag#Oncology hashtag#Partnering hashtag#Immunotherapy

[๐Ÿ“ขEfficacy of the STC-1010, a new allogeneic cancer vaccine in different colorectal cancer models #AACR24]

DOWNLOAD PR   [๐Ÿ“ข๐—œ๐—ป๐˜๐—ฒ๐—ฟ๐—ป๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐—ฎ๐—น #๐—”๐—”๐—–๐—ฅ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฐ] Brenus Pharma ๐—ฝ๐—ฟ๐—ฒ๐˜€๐—ฒ๐—ป๐˜๐—ฒ๐—ฑ ๐˜๐—ผ๐—ฑ๐—ฎ๐˜† ๐—ฝ๐—ฟ๐—ผ๐—บ๐—ถ๐˜€๐—ถ๐—ป๐—ด ๐—ฎ๐—ป๐—ฑ ๐—ฟ๐—ผ๐—ฏ๐˜‚๐˜€๐˜ ๐—ฎ๐—ป๐˜๐—ถ-๐˜๐˜‚๐—บ๐—ผ๐—ฟ ๐—ฒ๐—ณ๐—ณ๐—ถ๐—ฐ๐—ฎ๐—ฐ๐˜† ๐—ณ๐—ผ๐—ฟ ๐—ฆ๐—ง๐—–-๐Ÿญ๐Ÿฌ๐Ÿญ๐Ÿฌ, ๐—ป๐—ฒ๐˜…๐˜ ๐—ด๐—ฒ๐—ป๐—ฒ๐—ฟ๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ถ๐—บ๐—บ๐˜‚๐—ป๐—ผ๐˜๐—ต๐—ฒ๐—ฟ๐—ฎ๐—ฝ๐˜†, during the Association Cancer Research Annual meeting in San Diego. This is validating our innovative approach to fight #resistant hashtag#tumors and highlighting STC-1010’s potential in clinical trials for treating colorectal cancer ; second leading cause of cancer-death worldwide. An excellent consistency was observed with the 3 latest STC-1010 batches manufactured through standardized and scalable Brenusโ€™ Stimulated-Tumor-Cell (STC) platform production. ๐Ÿ”Žโ€œ๐—˜๐—ณ๐—ณ๐—ถ๐—ฐ๐—ฎ๐—ฐ๐˜† ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ ๐—ฆ๐—ง๐—–-๐Ÿญ๐Ÿฌ๐Ÿญ๐Ÿฌ ๐—ฎ ๐—ป๐—ฒ๐˜„ ๐—ฎ๐—น๐—น๐—ผ๐—ด๐—ฒ๐—ป๐—ฒ๐—ถ๐—ฐ ๐—ฐ๐—ฎ๐—ป๐—ฐ๐—ฒ๐—ฟ ๐˜ƒ๐—ฎ๐—ฐ๐—ฐ๐—ถ๐—ป๐—ฒ ๐—ถ๐—ป ๐—ฑ๐—ถ๐—ณ๐—ณ๐—ฒ๐—ฟ๐—ฒ๐—ป๐˜ ๐—ฐ๐—ผ๐—น๐—ผ๐—ฟ๐—ฒ๐—ฐ๐˜๐—ฎ๐—น ๐—ฐ๐—ฎ๐—ป๐—ฐ๐—ฒ๐—ฟ ๐—บ๐—ผ๐—ฑ๐—ฒ๐—น๐˜€โ€ย | Abstract 5003 https://lnkd.in/eibXkXpb Meet George Alzeeb Innovation Manager – ๐˜—๐˜ฉ๐˜‹ ๐˜ช๐˜ฏ ๐˜–๐˜ฏ๐˜ค๐˜ฐ๐˜ญ๐˜ฐ๐˜จ๐˜บ April 9, 2024, 9:00 AM – 12:30 PM (Pacific Daylight Time) ๐Ÿ“Section 39. Poster available here : https://lnkd.in/ei55Wurf STC doesnโ€™t just fight cancer as it is today; it anticipates how cancer will evolve tomorrow, training the patient’s immune system to recognize and destroy tumors, even as they change. We are building a strong portfolio in solid tumors, leveraging our patented STC platform, leading the path to a new generation of immunotherapies to change a paradigm in oncology. #BrenusPharma #ColorectalCancer #Immunotherapy #STC1010

AACR 2024 Annual meeting

Efficacy of the STC-1010 a new allogenic cancer vaccine in different colorectal cancer modelsย  F. Ghiringhelli et al, Cancer Res 2024 https://doi.org/10.1158/1538-7445.AM2024-5003 Link to Poster

๐ŸŽฌ BEHIND THE SCENE – Lionel Chalus, Head of Technical Operations

๐ŸŽฌ BEHIND THE SCENE – lionel Chalus, Head of Technical Operations Plongez dans l’aventure, racontรฉe par celles et ceux qui la vivent. SEE VIDEO Dans cette interview, Lionel nous ouvre les portes de son univers chez Brenus Pharma et partage son parcours inspirant en #biologiecellulaire et #immunothรฉrapies. Il nous dรฉvoile les coulisses de son poste de Responsable des opรฉrations techniques : orchestrer le transfert de technologie, la fabrication, ainsi que la coordination des efforts de nos partenaires pour dรฉvelopper le STC-1010, premier asset, pour lequel il a jouรฉ un rรดle dรฉterminant. Lionel incarne l’excellence opรฉrationnelle, alliant passion pour la science et rigueur, pour transformer les dรฉfis en rรฉussites. #BehindTheScene#DareToInnovate Rejoignez nous pour dรฉcouvrir l’histoire de lโ€™รฉquipe, une inspiration pour tous ceux engagรฉs dans la quรชte d’innovations significatives pour les patients. โ˜€๏ธ๐Ÿ”ฌ Join us to discover the team’s story, an inspiration for all those committed to find meaningful innovations for patients. โ˜€๏ธ๐Ÿ”ฌ โžก๏ธIn this interview, Lionel gives us a glimpse into his world at @Brenus Pharma and shares his inspiring journey in #cellbiology and #immunotherapies. He reveals the backstage of his role as Head of Technical Operations: orchestrating technology transfer, manufacturing, as well as coordinating the efforts of our partners to develop STC-1010, our first candidate, for which he played a decisive role. Lionel embodies operational excellence, combining a passion for science and precision to turn challenges into successes.

INCREASE IMMUNOGENICITY

Brenusโ€™ manufacturing process overpasses the lack of immunogenicity & educates the immune system ย withย visible and multi-specificย targets

REPRESENT HETEROGENEITY OF THE TARGETED INDICATION

Selection criteria of starting material (Allogeneic tumor cell lines)

  • Representative oncogenic drivers (TP53,BRAF,KRAS,โ€ฆ)
  • Cold & hot tumor cell lines
  • Resistances capacities (metabolic ; chemical & physical)

Increase antigenicity

Brenusโ€™ manufacturing process overpasses the lack of antigenicity & educates the immune system ย withย aย broadย &ย higherย qualityย range ofย tumorย antigens